Time to Let the Air Out
Time to Let the Air Out
If you think biotech stocks are headed for a breakout anytime soon, allow us to burst your bubble
FDA rules need tweaking
FDA rules need tweaking
The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have sent Wall Street reeling.
Will R&D Make Merck Hot Again?
Will R&D Make Merck Hot Again?
The drug giant gets out of the prescription business and bets it all on science.
Cracking the cancer code
Cracking the cancer code
Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments